UnitedHealth Group Incorporated (NYSE:UNH) is Cornerstone Investment Partners LLC's 9th Largest Position

Cornerstone Investment Partners LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 125,899 shares of the healthcare conglomerate's stock after selling 2,059 shares during the period. UnitedHealth Group accounts for about 3.7% of Cornerstone Investment Partners LLC's holdings, making the stock its 9th biggest position. Cornerstone Investment Partners LLC's holdings in UnitedHealth Group were worth $66,282,000 as of its most recent filing with the SEC.

Other hedge funds have also added to or reduced their stakes in the company. Robbins Farley bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $25,000. Richelieu Gestion SA bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC increased its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC increased its holdings in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate's stock worth $33,000 after acquiring an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA increased its holdings in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate's stock worth $35,000 after acquiring an additional 40 shares during the period. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on UNH. Oppenheimer reaffirmed an "outperform" rating and set a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. Truist Financial reaffirmed a "buy" rating and set a $600.00 target price on shares of UnitedHealth Group in a report on Wednesday. Bank of America reissued a "buy" rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $596.00 to $555.00 and set an "outperform" rating on the stock in a report on Wednesday. Finally, Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating on the stock in a report on Monday, April 8th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $570.05.

UnitedHealth Group Trading Up 1.6 %

Shares of UnitedHealth Group stock traded up $8.11 during trading on Friday, reaching $501.29. The company's stock had a trading volume of 6,616,632 shares, compared to its average volume of 4,553,088. The company has a market cap of $462.16 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.31 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm's 50-day moving average is $488.63 and its two-hundred day moving average is $515.13. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts' expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm's revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.26 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.74 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.50%. UnitedHealth Group's payout ratio is currently 45.97%.

Insider Transactions at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm's stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company's stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.